Related to Product and Service Firms Challenged by Uncertain NIH Funding, Polarization of Sequencing

• Charles River to Take Over Sino-U.S. CRO WuXi in Deal Worth $1.6B
  
• Microsynth Supplies Sequencing Customers with CLC Bio’s Analysis Software
  
• GATC to Sequence Pediatric Brain Tumors for PedBrainTumor Consortium
  
• Helicos Nixes 40 Employees to Focus on Diagnostics
  
• Broad Institute to Replace Illumina’s Genome Analyzer IIx Systems with HiSeq 2000 Units
  
• Gen-Probe Invests $50M in PacBio to Fortify Single-Molecule Sequencing Platform
  
• NIAID Commissions TRI and Icon for Clinical Support Services with $19M
  
• Icon Sets Up Additional Lab Facility in China
  
• Roche and IBM Set Sights on $100–1,000 Genome Nanopore Sequencing Platform
  
• PPD and Lovelace Biomedical and Environmental Research Institute Partner to Provide Services
  
• Illumina Gives Researchers Access to Large-Scale Whole Human Genome Sequencing
  
• Charles River Pays WuXi $30M to Renege on $1.6B Acquisition Deal
  
• ADME Services Firm Cyprotex Buys Apredica for £2.68M to Enter Toxicology Market
  
• TRI Wins up to $75M Contract to Provide AIDS-Related CRO Services
  
• Elephant Capital Takes £8M Stake in ClinTec
  
• Veritas to Market Epistem’s Epithelial Stem Cell-Based Research Services in Japan
  
• Ambry Confirmed as First U.S. CSP for NimbleGen Sequence-Capture Solution
  
• GATC Opens Unit to Achieve Goal of Sequencing 100,000 Human Genomes by 2014
  
• Eurofins to Provide Roche GS Junior for Smaller-Scale Projects
  
• Sanofi-Aventis Sells Two CMC Sites to Covance for $25M in $1–2B Services Deal